Evolus (NASDAQ:EOLS) reported fourth-quarter and full-year 2025 results and outlined its priorities for 2026, emphasizing a ...
When Hend Alqaderiwas studying how saliva could predict the risk of diabetes or the severity of a coronavirus infection, she collected a lot of saliva samples-thousands, measuring hundreds of bacteria ...
TRACY, CA, UNITED STATES, February 27, 2026 /EINPresswire.com/ -- Driving Global Brand Strategy, Mentorship, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results